Literature DB >> 12121937

In vitro activities of position 2 substitution-bearing 6-nitro- and 6-amino-benzothiazoles and their corresponding anthranilic acid derivatives against Leishmania infantum and Trichomonas vaginalis.

Florence Delmas1, Carole Di Giorgio, Maxime Robin, Nadine Azas, Monique Gasquet, Claire Detang, Muriel Costa, Pierre Timon-David, Jean-Pierre Galy.   

Abstract

6-Nitro- and 6-amino-benzothiazoles bearing different chains in position 2 and their corresponding anthranilic acid derivatives were investigated for their in vitro antiparasitic properties against parasites of the species Leishmania infantum and Trichomonas vaginalis compared to their toxicity towards human monocytes. Biological investigations established that the antiprotozoal properties depended greatly on the chemical structure of the position 2 substitution-bearing group. Compound C1, 2-[(2-chloro-benzothiazol-6-yl) amino] benzoic acid, demonstrated an interesting antiproliferative activity towards parasites of the species T. vaginalis, while compound C11, 2-([2-[(2-hydroxyethyl) amino]-benzothiazol-6-yl] amino) benzoic acid, exhibited a promising activity against parasites of the species L. infantum in their intracellular amastigote form. Additional experiments established that compound C11, which was poorly toxic against the promastigote and the extracellular amastigote forms of the parasite, could improve host-protective mechanisms against Leishmania by preventing parasite internalization by macrophages and stimulating NO production, by means of a mechanism synergistically enhanced by the presence of gamma interferon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121937      PMCID: PMC127338          DOI: 10.1128/AAC.46.8.2588-2594.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds.

Authors:  V V Poroikov; D A Filimonov; Y V Borodina; A A Lagunin; A Kos
Journal:  J Chem Inf Comput Sci       Date:  2000 Nov-Dec

2.  The effect of riluzole treatment in rats on the survival of injured adult and grafted embryonic motoneurons.

Authors:  A Nógrádi; G Vrbová
Journal:  Eur J Neurosci       Date:  2001-01       Impact factor: 3.386

Review 3.  How do protozoan parasites survive inside macrophages?

Authors:  C Bogdan; M Röllinghoff
Journal:  Parasitol Today       Date:  1999-01

Review 4.  Nitric oxide in parasitic infections.

Authors:  L R Brunet
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

5.  Prediction of n-octanol/water partition coefficients from PHYSPROP database using artificial neural networks and E-state indices.

Authors:  I V Tetko; V Y Tanchuk; A E Villa
Journal:  J Chem Inf Comput Sci       Date:  2001 Sep-Oct

6.  Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn).

Authors:  P Kennel; F Revah; G A Bohme; R Bejuit; P Gallix; J M Stutzmann; A Imperato; J Pratt
Journal:  J Neurol Sci       Date:  2000-11-01       Impact factor: 3.181

7.  Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia.

Authors:  H J Bae; Y S Lee; D W Kang; J S Koo; B W Yoon; J K Roh; J S Gu
Journal:  Neurosci Lett       Date:  2000-11-10       Impact factor: 3.046

Review 8.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 9.  A review of the geographic distribution and epidemiology of leishmaniasis in the New World.

Authors:  G Grimaldi; R B Tesh; D McMahon-Pratt
Journal:  Am J Trop Med Hyg       Date:  1989-12       Impact factor: 2.345

10.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

View more
  6 in total

1.  In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives.

Authors:  Sara Robledo; Edison Osorio; Diana Muñoz; Luz Marina Jaramillo; Adriana Restrepo; Gabriel Arango; Iván Vélez
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  3-(Benzothia-zol-2-yl)-3-(prop-2-yn-yl)hex-5-yn-2-one.

Authors:  Yamna Baryala; Abdelfettah Zerzouf; Moussa Salem; El Mokhtar Essassi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-17

3.  1,4-Bis[2-(1,3-benzothia-zol-2-yl)phen-oxy]butane.

Authors:  Orhan Büyükgüngör; Arzu Ozek; Senem Karahan; Elif Subaşı
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-30

4.  2-(1,3-Benzothia-zol-2-yl)-6-eth-oxy-phenol.

Authors:  D Lakshmanan; R Madhan Raj; R Selvakumar; M Bakthadoss; S Murugavel
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-06

5.  2-(2H-1,3-Benzodioxol-5-yl)-1,3-benzo-thia-zole.

Authors:  D Lakshmanan; S Murugavel; R Selvakumar; M Bakthadoss
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-03

6.  Synthesis, PASS-Predication and in Vitro Antimicrobial Activity of Benzyl 4-O-benzoyl-α-l-rhamnopyranoside Derivatives.

Authors:  Mohammed Mahbubul Matin; Amit R Nath; Omar Saad; Mohammad M H Bhuiyan; Farkaad A Kadir; Sharifah Bee Abd Hamid; Abeer A Alhadi; Md Eaqub Ali; Wageeh A Yehye
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.